0.66
-0.0103(-1.54%)
Currency In USD
| Previous Close | 0.67 |
| Open | 0.67 |
| Day High | 0.68 |
| Day Low | 0.65 |
| 52-Week High | 2.13 |
| 52-Week Low | 0.28 |
| Volume | 213,670 |
| Average Volume | 6.53M |
| Market Cap | 29.41M |
| PE | -0.55 |
| EPS | -1.21 |
| Moving Average 50 Days | 0.66 |
| Moving Average 200 Days | 0.5 |
| Change | -0.01 |
If you invested $1000 in Harvard Bioscience, Inc. (HBIO) 10 years ago, it would be worth $228.03 as of January 08, 2026 at a share price of $0.67. Whereas If you bought $1000 worth of Harvard Bioscience, Inc. (HBIO) shares 5 years ago, it would be worth $158.86 as of January 08, 2026 at a share price of $0.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
GlobeNewswire Inc.
Dec 17, 2025 12:30 PM GMT
Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial FlexibilityBroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities HOLLISTON, Ma
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
GlobeNewswire Inc.
Oct 30, 2025 12:00 PM GMT
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call t
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
GlobeNewswire Inc.
Sep 16, 2025 11:00 AM GMT
- Strategic expansion with trusted partner enhances customer reachHOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider of innovative laboratory equi